Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease

Abstract Introduction Unsupervised digital cognitive testing is an appealing means to capture subtle cognitive decline in preclinical Alzheimer's disease (AD). Here, we describe development, feasibility, and validity of the Boston Remote Assessment for Neurocognitive Health (BRANCH) against in‐perso...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kathryn V. Papp, Aubryn Samaroo, Hsiang‐Chin Chou, Rachel Buckley, Olivia R. Schneider, Stephanie Hsieh, Daniel Soberanes, Yakeel Quiroz, Michael Properzi, Aaron Schultz, Iván García‐Magariño, Gad A. Marshall, Jane G. Burke, Raya Kumar, Noah Snyder, Keith Johnson, Dorene M. Rentz, Reisa A. Sperling, Rebecca E. Amariglio
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2021-01-01
Edice:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Témata:	digital biomarkers mobile testing preclinical Alzheimer's disease unsupervised assessment
On-line přístup:	https://doi.org/10.1002/dad2.12243
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!